Mesoblast Limited (ASX:MSB)
2.660
+0.120 (4.72%)
At close: Dec 5, 2025
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 3.41 billion as of December 5, 2025. Its market cap has increased by 101.36% in one year.
Market Cap
3.41B
Enterprise Value
3.36B
Revenue
26.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.66
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 3.41B, an increase of 4,356.96%. That is a compound annual growth rate of 19.84%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.01B |
| Pro Medicus | 26.57B |
| Cochlear | 17.94B |
| Sonic Healthcare | 11.43B |
| Ramsay Health Care | 8.54B |
| Ansell | 5.20B |
| Telix Pharmaceuticals | 4.93B |
| Neuren Pharmaceuticals | 2.42B |